top of page

Diversity Domain

The Diversity course for the LeADERS program, CHP 400: Ethics in Healthcare Administration, gave an overview of ethics in the healthcare setting. Understanding and respecting individual personal, social, religious, and cultural differences is essential. This course provided case studies and examples of situations in which ethical conflicts arose due to diverse perspectives. These exercises developed my ability to navigate complex ethical dilemmas in healthcare.

CHP 400: Ethics in Healthcare Administration

In the Ethics in Healthcare Administration course, I was exposed to various situations where ethical dilemmas may arise. Through detailed case studies, I gained insights into real-world scenarios that healthcare professionals often encounter. These scenarios included religious, cultural, and personal barriers and the ethical implications of disclosing personal health information for the greater good. They also highlighted the importance of understanding and respecting diverse patient backgrounds, and the need to uphold their preferences and autonomy in all decision-making processes, a key aspect of patient-centered care.

 

This course provided insight into the types of differences that I will encounter as a healthcare professional and an ethical framework for navigating the complexities of the healthcare setting. This course also introduced me to the IRAC (Issue, Rule, Analysis, Conclusion) approach to examining an ethical dilemma. The insights gained using this approach have equipped me to navigate conflicts concerning cultural, social, and personal differences, fostering a diverse and inclusive professional environment. 

​

To illustrate the application of these concepts, I have included a sample paper from this class that contains two case studies. The first case is about a patient with a subdural hematoma and includes the five components of medical malpractice cases. The second uses an IRAC analysis to analyze the ethics of treating patients with Ivermectin for COVID-19 despite COVID not being an FDA-approved indication. 

bottom of page